Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion | PLOS ONE
Case Study 1: Relapser to PEG IFN-Alfa + RBV (Slides With Transcript)
Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus | Antimicrobial Agents and Chemotherapy
Raised Serum Transaminases during Treatment with Pegylated Interferon for Chronic Hepatitis C
Characterization and biologic activity of PPB-PEG-IFN-γ. A) Schematic... | Download Scientific Diagram
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155 | Annals of Hepatology
End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB - Journal of Hepatology
ASPIRE Study: SMV + PEG-IFN + RBV for genotype 1 experienced patients - ppt download
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study | PLOS ONE
Chemical structure of peginterferon α-2a and α-2b. Abbreviations:... | Download Scientific Diagram
:max_bytes(150000):strip_icc()/pegasys-568530305f9b586a9e15ec79.jpg "Pegylated Interferon: Definition, Types, Uses")
Pegylated Interferon: Definition, Types, Uses
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Que faisons nous ? — Centre International de Recherche en Infectiologie
Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study - ScienceDirect
Adjustment during Peg-IFN treatment for HBeAg-negative CHB patients.... | Download Scientific Diagram
Peg-INF – Ferozsons Laboratories Limited
Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
Differences on the PEGylation strategy for PegIntron ® (PEG-IFN2b) and... | Download Scientific Diagram
Chronic treatment with peg-IFN-α reduces peripheral disease parameters... | Download Scientific Diagram
JCM | Free Full-Text | Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens
